ArticleScandinavian journal of immunology2021

A pilot study towards the immunological effects of omalizumab treatment used to facilitate oral immunotherapy in peanut-allergic adolescents.

Marieke van der Heiden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.